Cite
MLA Citation
Matilde Sánchez-Conde et al.. “Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study.” International journal of infectious diseases, vol. 123, 2022, pp. 97–103. http://access.bl.uk/ark:/81055/vdc_100167538540.0x000020